Phase IIa trial investigating verubulin with and without oxaliplatin in patients with recurring glioblastoma

Trial Profile

Phase IIa trial investigating verubulin with and without oxaliplatin in patients with recurring glioblastoma

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Sep 2011

At a glance

  • Drugs Oxaliplatin; Verubulin
  • Indications Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Sep 2011 Status changed from recruiting to completed.
    • 03 Feb 2011 Data from a second sub-group of recurrent glioblastoma patients who are naive to Avastin are expected in the first half of 2011, according to a Myrexis media release.
    • 16 Sep 2008 Preliminary tolerability results presented at ESMO
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top